NDC 0409-0125 – Labetalol Hydrochloride

Labetalol Hydrochloride 5 mg/mL · Injection, Solution · Intravenous

Human Prescription Drug 2 recalls

Product NDC0409-0125

Product details

Brand name
Labetalol Hydrochloride
Generic name
Labetalol Hydrochloride
Labeler
Hospira, Inc.
Dosage form
Injection, Solution
Route
Intravenous
Marketing category
ANDA · ANDA075240
Marketed since
August 7, 2023
Listing expires
December 31, 2027
Pharmacologic class
beta-Adrenergic Blocker

Active ingredients

Uses, dosage, side effects and warnings for Labetalol Hydrochloride →

Package NDC codes (1)

Package NDCDescriptionSince
0409-0125-2525 VIAL, MULTI-DOSE in 1 TRAY (0409-0125-25) / 20 mL in 1 VIAL, MULTI-DOSE (0409-0125-01)Aug 7, 2023

Recalls mentioning this NDC

Other Labetalol Hydrochloride products